Prospective Study on Incidence, Risk Factors and Outcome of Recurrent Clostridioides difficile InfectionsGuido Granata, Paolo Bonfanti, Raffaella Borromeo et al.|Journal of Clinical Medicine|2021Cited by 15
Comparison of meropenem-vaborbactam with ceftazidime-avibactam in the treatment of carbapenem-resistant Enterobacterales infectionsLuca Mezzadri, Paolo Bonfanti, Elena Ricci et al.|Journal of Global Antimicrobial Resistance|2024Cited by 4
Clinical use of dalbavancin in the Italian SUSANA cohort (SUrveillance of SAfety and outcome of New Antibiotics).Sara Tordi, Giuseppe Vittorio De Socio, Elena Ricci et al.|PubMed|2025Cited by 1
Recurrence of Clostridioides difficile infection: A multicenter study on incidence and risk factorsMaria Adriana Cataldo, Nicola Petrosillo, Guido Granata et al.|International Journal of Infectious Diseases|2020Cited by 0